HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of antiseptic agents on interleukin-8 release and transmigration of polymorphonuclear neutrophils in a human in vitro model of peritonitis.

AbstractBACKGROUND:
The aim of this study was to evaluate the influence of taurolidine (TAU) and polyhexanid (POLY) on basic inflammatory reactions during peritonitis by using an in vitro model of human peritoneum.
MATERIALS AND METHODS:
Human umbilical vein endothelial cells (HUVEC) and human peritoneal mesothelial cells (HPMC; concentration: 2x10(5)/cm2) were brought on a collagen-coated filter insert with 3-microm pore size (HUVEC on the bottom, HPMC on the top), thus resulting in a two-chamber peritoneal model. After 5 days, confluence of the cells was reached, and HPMC were stimulated with 0.5 mL of TNF-alpha (10 microg/mL) for 4 h. Afterwards, 0.5 mL of TAU (1% and 2%) or 0.5 mL of POLY (0.1% and 0.2%) solution were added to the upper (HPMC) compartment. Polymorphonuclear neutrophils (PMN, 10(6)/mL) were placed in the lower compartment 1 h later. After 2 and 6 h, aliquots were taken from the upper compartment and transmigrated PMN were counted. Interleukin-8 (IL-8) concentrations were measured in both compartments by chemiluminescent enzyme immunometric assay. Expression of the adhesion molecules P-selectin and intercellular adhesion molecule-1 (ICAM-1) was assessed by immunohistochemistry. Controls were either TNF-alpha-stimulated HPMC without any antiseptic agents, or stimulated HPMC where TNF-alpha had been substituted by culture medium. Each experiment was performed in triplicate.
RESULTS:
Stimulation with TNF-alpha led to a time-dependent increase of IL-8 secretion to the apical compartment resulting in a gradient between both chambers, as well as to a time-dependent increase of PMN transmigration and expression of adhesion molecules. IL-8 gradients and PMN migration were significantly higher as compared to the other groups (p<0.05). After substitution of the stimulus by culture medium, significantly less IL-8 was measured in both compartments. PMN transmigration was almost absent (p<0.05). Addition of POLY and TAU led to comparable low IL-8 gradients with concomitant low PMN transmigration. The initially detected expression of adhesion molecules significantly decreased during the observation time. The IL-8 gradient in all groups correlated significantly with PMN transmigration (r=0.74226; p<0.0001).
CONCLUSION:
The diminished IL-8 response together with low PMN transmigration rates after addition of TAU and POLY may reflect either antiinflammatory effects or cellular damage.
AuthorsWolfgang Sendt, Erfan Mansouri, Annette Schmitt-Graeff, Guido Wolff-Vorbeck, Ulrich Schöffel
JournalSurgical infections (Surg Infect (Larchmt)) Vol. 3 Issue 3 Pg. 235-44 ( 2002) ISSN: 1096-2964 [Print] United States
PMID12542924 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Infective Agents, Local
  • Anti-Inflammatory Agents
  • Biguanides
  • Interleukin-8
  • P-Selectin
  • Thiadiazines
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • Taurine
  • polihexanide
  • taurolidine
Topics
  • Anti-Infective Agents, Local (pharmacology)
  • Anti-Inflammatory Agents (pharmacology)
  • Biguanides (pharmacology)
  • Cell Movement
  • Dose-Response Relationship, Drug
  • Endothelial Cells (drug effects, metabolism)
  • Endothelium, Vascular (cytology)
  • Humans
  • In Vitro Techniques
  • Intercellular Adhesion Molecule-1 (biosynthesis)
  • Interleukin-8 (biosynthesis)
  • Neutrophils (drug effects, physiology)
  • P-Selectin (biosynthesis)
  • Peritoneal Cavity (cytology)
  • Peritonitis (immunology, metabolism)
  • Taurine (analogs & derivatives, pharmacology)
  • Thiadiazines (pharmacology)
  • Time Factors
  • Tumor Necrosis Factor-alpha (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: